Comparison

Recombinant Human IFN-alpha 2b (E. coli)

Item no. CS-CRI004C
Manufacturer Cell Sciences
Amount 1.0 mg
Category
Type Proteins
Specific against Human (Homo sapiens)
Host E.coli
Purity >96.0% by HPLC and SDS-PAGE
Sequence MCDLPQTHSL GSRRTLMLLA QMRRISLFSC LKDRHDFGFP QEEFGNQFQK AETIPVLHEM IQQIFNLFST KDSSAAWDET LLDKFYTELY QQLNDLEACV IQGVGVTETP LMKEDSILAV RKYFQRITLY LKEKKYSPCA WEVVRAEIMR SFSLSTNLQE SLRSKE
ECLASS 10.1 32160409
ECLASS 11.0 32160409
UNSPSC 12352202
Similar products IFNA, alpha-2a interferon, INFA2, MGC125764, MGC125765, RP11-354P17.2, interferon alpha-2, leIF A, IFN-alpha-2, interferon alpha A, interferon alpha-A, interferon alpha 2b
Available
Manufacturer - Category
Biomolecules
Storage Conditions
This lyophilized preparation is stable at 2-8C, but should be kept desiccated at -20C for long term storage. Upon reconstitution, the preparation is stable for up to one week at 2-8C. For maximal stability, apportion the reconstituted preparation into working aliquots and store at -20C to -80C. Avoid repeated freeze/thaw cycles.
Molecular Weight
ca.19.4 kDa
Description
At least 23 different variants of IFN-alpha are known. The individual proteins have molecular masses between 19-26 kDa and consist of proteins with lengths of 156-166 and 172 amino acids. All IFN-alpha subtypes possess a common conserved sequence region between amino acid positions 115-151 while the amino-terminal ends are variable. Many IFN-alpha subtypes differ in their sequences at only one or two positions. Naturally occurring variants also include proteins truncated by 10 amino acids at the carboxy-terminal end. Recombinant human IFN-alpha 2b is a single, non-glycosylated polypeptide chain containing 166 amino acids.
Formulation
Lyophilized from a 0.2 um filtered solution in PBS, pH 7.4.
Reconstitution
Centrifuge vial prior to opening. Add sterile distilled water or aqueous buffer to a concentration of 0.1-1.0 mg/ml. Further dilutions should be made in appropriate buffered solutions.
Specificity
The specific activity as determined in a viral resistance assay was found to be no less than 1.0 x 108 IU/mg.
Biological Activity
Fully biologically active when compared to standard.
Endotoxin Level
Less than 1EU/ug as determined by LAL method.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 1.0 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close